Found: 5
Select item for more details and to access through your institution.
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan.
- Published in:
- 2023
- By:
- Publication type:
- Letter
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 8, p. 861, doi. 10.1080/0284186X.2023.2238544
- By:
- Publication type:
- Article
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 4, p. 409, doi. 10.1080/0284186X.2021.2023213
- By:
- Publication type:
- Article
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4846, doi. 10.3390/cancers13194846
- By:
- Publication type:
- Article
Sino-nasal Cancer in Denmark 1982-1999 - A Nationwide Survey.
- Published in:
- Acta Oncologica, 2001, v. 40, n. 1, p. 19, doi. 10.1080/028418601750070993
- By:
- Publication type:
- Article